Long-term proton pump inhibitor use does not raise hip fracture risk
Intended for healthcare professionals
Journal scan Previous     Next

Long-term proton pump inhibitor use does not raise hip fracture risk

Ruth Sander Independent consultant, Care of the older person

Proton pump inhibitors (PPIs) reduce the production of stomach acid and are effective drugs for gastro-oesophageal reflux disease that are commonly prescribed to older people.

Nursing Older People. 30, 4, 13-13. doi: 10.7748/nop.30.4.13.s11

Want to read more?

Already subscribed? Log in

OR

Unlock full access to RCNi Plus today

Save over 50% on your first 3 months

Your subscription package includes:
  • Unlimited online access to all 10 RCNi Journals and their archives
  • Customisable dashboard featuring 200+ topics
  • RCNi Learning featuring 180+ RCN accredited learning modules
  • RCNi Portfolio to build evidence for revalidation
  • Personalised newsletters tailored to your interests
Subscribe
RCN student member? Try Nursing Standard Student

Alternatively, you can purchase access to this article for the next seven days. Buy now

Or